Literature DB >> 803480

Transformation of leucine and rifampin traits in Neisseria gonorrhoeae with deoxyribonucleic acid from homologous and heterologous origins.

D O Wood, G H Brownell.   

Abstract

A leucine-requiring, rifampin-sensitive strain of Neisseria gonorrhoeae was transformed to a leucine-nonrequiring, rifampin-resistant phenotype with deoxyribonucleic acid (DNA) obtained from both N. meningitidis and N. gonorrhoeae. The transforming efficiency of the meningococcal DNA was about 10- to 100-fold less than that of the homologous gonococcal DNA. A chemically defined medium that would support growth of most gonococcal isolates was used as a complete medium. A minimal medium was used for selection of Leu+ transformants. N-methyl-N'-nitro-N-nitrosoguanidine was used as a mutagen for isolating leucine prototrophs from leucine-requiring isolates of N. gonorrohoeae.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803480      PMCID: PMC245954          DOI: 10.1128/jb.121.2.471-474.1975

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  7 in total

1.  A defined agar medium for genetic transformation of Neisseria meningitidis.

Authors:  B W CATLIN; G M SCHLOER
Journal:  J Bacteriol       Date:  1962-03       Impact factor: 3.490

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

3.  Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing.

Authors:  B W Catlin
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

4.  NEISSERIA GONORRHOEAE IDENTIFICATION IN DIRECT SMEARS BY A FLUORESCENT ANTIBODY-COUNTERSTAIN METHOD.

Authors:  L A WHITE; D S KELLOGG
Journal:  Appl Microbiol       Date:  1965-03

5.  Genetic transformation of Neisseria gonorrhoeae to streptomycin resistance.

Authors:  P F Sparling
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

6.  Neisseria gonorrhoeae auxotyping: differentiation of clinical isolates based on growth responses on chemically defined media.

Authors:  K Carifo; B W Catlin
Journal:  Appl Microbiol       Date:  1973-09

7.  Genetic transformation of biosynthetically defective Neisseria gonorrhoeae clinical isolates.

Authors:  B W Catlin
Journal:  J Bacteriol       Date:  1974-10       Impact factor: 3.490

  7 in total
  7 in total

1.  Differences in susceptibilities of virulent strains and avirulent strains of Neisseria gonorrhoeae to antimicrobial agents.

Authors:  D V Lim
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

2.  Genetic transformation of pilation and virulence into Neisseria gonorrhoeae T4.

Authors:  E S Baron; A K Saz
Journal:  J Bacteriol       Date:  1978-02       Impact factor: 3.490

3.  Temperature-sensitive mutants of Neisseria gonorrhoeae.

Authors:  R D Wharton; L Zubrzycki
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

4.  WSJM, a simple chemically defined medium for growth of Neisseria gonorrhoeae.

Authors:  T P Wong; R K Shockley; K H Johnston
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

5.  Intrageneric transformation of neisseria gonorrhoeae and neisseria perflava to streptomycin resistance and nutritional independence.

Authors:  A Siddiqui; I D Goldberg
Journal:  J Bacteriol       Date:  1975-12       Impact factor: 3.490

6.  Transfer of plasmid-borne beta-lactamase in Neisseria gonorrhoeae.

Authors:  E S Baron; A K Saz; D J Kopecko; J A Wohlhieter
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

7.  Nucleotide sequence homology between the immunoglobulin A1 protease genes of Neisseria gonorrhoeae, Neisseria meningitidis, and Haemophilus influenzae.

Authors:  J M Koomey; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.